Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Schwannomatosis × siltuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 7 Cytokine Release Syndrome 3 Prostatic Neoplasms 2 Neoplasms, Plasma Cell 2 Schwannomatosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Neurilemmoma 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Kidney Neoplasms 1 Immunoglobulin Light-chain Amyloidosis 1 Chronic Pain 1 Carcinoma, Renal Cell 1 Advanced Malignant Solid Neoplasm 1

Interventions

tanezumab 1 siltuximab 1 erenumab 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05684692 2025-10-30

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Massachusetts General Hospital

Phase 2 Recruiting

Schwannomatosis, Neurilemmoma, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡